Contact Us
Find A Doctor

Treatment of Patients with Diabetic Macular Edema

Principal Investigator

Richard Rosen, MD

Enrollment Status

Completed

Objective

To evaluate the safety and efficacy of the 700 μg DEX PS DDS Applicator System (700 μg dexamethasone) and 350 μg DEX PS DDS Applicator System (350 μg dexamethasone) in patients with diabetic macular edema.

Eligibility:

Contact Principal Investigator/Coordinator

 

 

Contact Us

Dr. Richard Rosen, Principal InvestigatorTel: (212) 979-4284

Katy Tai, Research ManagerTel: (212) 979-4251

Address310 E. 14th StreetNew York, NY 10003

View all locations